Dividend compounder review

ARWR

Arrowhead Pharmaceuticals Inc · NASDAQ · US

Healthcare · Biotechnology

Chart Factor Intelligence Back to Screener
Score39.00/100
Confidence78.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 14.0 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 13.0 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 3.0 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 9.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$-1.6M
Free Cash Flow$156.9M
FCF Covers DividendUnknown
Debt / Equity2.31
P/E-
Revenue Growth 5Y56.6%
Net Margin-48.4%
ROE-42.4%
Price vs Trend13.3%
3Y Return111.5%
5Y Return-17.5%
CurrencyUSD
Warnings

Review flags

No usable dividend history found.
Debt to equity is elevated at 2.31.
Dividend diary

Activity record

ARWR dividend review warning Warning · Warning

Debt to equity is elevated at 2.31.